Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinrich Elinzano

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Clinics in Geriatric Medicine|April 16, 2021
Cancer and Peripheral Nerve DiseaseJonathan Sarezky, George Sachs, Heinrich Elinzano, et al.
Journal of Neuro-Oncology|April 29, 2008
Irinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safetyTyler Y Kang, Tony Jin, Heinrich Elinzano, et al.
Rhode Island Medical Journal (2013)|July 28, 2025
Glioblastoma: Epidemiology and Imaging-Based ReviewJoseph Madour, Justin Bessette, Joey Z Gu, et al.
Journal of Neuropathology and Experimental Neurology|September 30, 2022
Prostate-Specific Membrane Antigen Expression in Meningioma: A Promising Theranostic TargetTeddi Tubre, Sean Hacking, Abigail Alexander, et al.
American Journal of Clinical Oncology|December 2, 2014
Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade GliomaJerrold L Boxerman, Benjamin M Ellingson, Suriya Jeyapalan, et al.
American Journal of Clinical Oncology|December 7, 2020
Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma: BrUOG329, A Phase I Brown University Oncology Research Group TrialHeinrich Elinzano, Steven Toms, Jordan Robison, et al.
Neuro-Oncology|March 3, 2011
Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 casesJacob G Scott, John H Suh, Paul Elson, et al.
Journal of Neurosurgery|May 10, 2011
Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical articleOvidiu Marina, John H Suh, Chandana A Reddy, et al.
Clinical & Experimental Metastasis|September 6, 2025
FLAIR extending beyond a quadrant (FEQ) of the cerebrum as a qualitative imaging biomarker: a conceptual proposition and proof-of-principleAli A Alattar, Jiri Bartek, Carlin Chuck, et al.
Frontiers in Neurology|January 27, 2023
Dimorphic glioblastoma with glial and epithelioid phenotypes: Clonal evolution and immune selectionMark Willy L Mondia, Michael A Kritselis, John E Donahue, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Clinics in Geriatric Medicine|April 16, 2021
Cancer and Peripheral Nerve DiseaseJonathan Sarezky, George Sachs, Heinrich Elinzano, et al.
Journal of Neuro-Oncology|April 29, 2008
Irinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safetyTyler Y Kang, Tony Jin, Heinrich Elinzano, et al.
Rhode Island Medical Journal (2013)|July 28, 2025
Glioblastoma: Epidemiology and Imaging-Based ReviewJoseph Madour, Justin Bessette, Joey Z Gu, et al.
Journal of Neuropathology and Experimental Neurology|September 30, 2022
Prostate-Specific Membrane Antigen Expression in Meningioma: A Promising Theranostic TargetTeddi Tubre, Sean Hacking, Abigail Alexander, et al.
American Journal of Clinical Oncology|December 2, 2014
Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade GliomaJerrold L Boxerman, Benjamin M Ellingson, Suriya Jeyapalan, et al.
American Journal of Clinical Oncology|December 7, 2020
Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma: BrUOG329, A Phase I Brown University Oncology Research Group TrialHeinrich Elinzano, Steven Toms, Jordan Robison, et al.
Neuro-Oncology|March 3, 2011
Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 casesJacob G Scott, John H Suh, Paul Elson, et al.
Journal of Neurosurgery|May 10, 2011
Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical articleOvidiu Marina, John H Suh, Chandana A Reddy, et al.
Clinical & Experimental Metastasis|September 6, 2025
FLAIR extending beyond a quadrant (FEQ) of the cerebrum as a qualitative imaging biomarker: a conceptual proposition and proof-of-principleAli A Alattar, Jiri Bartek, Carlin Chuck, et al.
Frontiers in Neurology|January 27, 2023
Dimorphic glioblastoma with glial and epithelioid phenotypes: Clonal evolution and immune selectionMark Willy L Mondia, Michael A Kritselis, John E Donahue, et al.
Pageof 3